Desquamation of human coronary artery endothelium by human mast cell proteases: implications for plaque erosion.
about
Emerging role of mast cells and macrophages in cardiovascular and metabolic diseasesEndothelial dysfunction and coronary artery disease: assessment, prognosis, and treatmentMast cells as effectors in atherosclerosisStress triggers coronary mast cells leading to cardiac eventsCathepsin G activity lowers plasma LDL and reduces atherosclerosisOSBP-related protein 8 (ORP8) suppresses ABCA1 expression and cholesterol efflux from macrophagesA vascular biology network model focused on inflammatory processes to investigate atherogenesis and plaque instability.An emerging role of mast cells in cerebral ischemia and hemorrhage.Proteolysis sensitizes LDL particles to phospholipolysis by secretory phospholipase A2 group V and secretory sphingomyelinase.Mast cells as early responders in the regulation of acute blood-brain barrier changes after cerebral ischemia and hemorrhage.Mast cell tryptases and chymases in inflammation and host defense.Cysteinyl cathepsins and mast cell proteases in the pathogenesis and therapeutics of cardiovascular diseases.Mast cell stabilization: novel medication for obesity and diabetes.Mast cells: multipotent local effector cells in atherothrombosis.Mast cells in vulnerable atherosclerotic plaques--a view to a kill.Coronary stents, hypersensitivity reactions, and the Kounis syndrome.Pharmaceutical stabilization of mast cells attenuates experimental atherogenesis in low-density lipoprotein receptor-deficient mice.Mast cell chymase and tryptase as targets for cardiovascular and metabolic diseases.Mast cells: pivotal players in cardiovascular diseases.Mast cell chymase and tryptase in abdominal aortic aneurysm formation.Mast cells in human and experimental cardiometabolic diseases.Discriminating between the activities of human cathepsin G and chymase using fluorogenic substrates.Management of atherosclerosis with antiallergic medicine: a lesson from the mouse model.The role of tryptase and anti-type II collagen antibodies in the pathogenesis of idiopathic epiretinal membranes.Multifunctional Role of Chymase in Acute and Chronic Tissue Injury and Remodeling.Complement factor C5a as mast cell activator mediates vascular remodelling in vein graft disease.Chymase released from hypoxia-activated cardiac mast cells cleaves human apolipoproteinA-I at Tyr192 and compromises its cardioprotective activity.Immunological aspects of atherosclerosis: Figure 1
P2860
Q26825467-75334D75-9896-4E87-A83E-B1DBB5CCC138Q26853087-550979A8-A17E-4629-807B-7CDA90786A85Q26995160-21D96516-1DD5-4AC0-98F8-31EBD7A219D9Q27022598-DFAE8BE3-B803-49E5-B5B4-CC7E3D6D2715Q28245234-6123970A-7EC6-4314-AAA7-65B0065CC933Q28256750-E4E524E6-5A20-4DC9-B2CC-D9E8925750AAQ30597305-EB1177B0-38CC-459D-A31D-BB1FB0D9153DQ33438542-4BE57165-2F99-4AA3-A805-1C86FC7361FDQ33901989-D38C5EB1-21C6-474F-993F-E73331F7B82DQ34093771-7433D3D2-FC03-49B8-A3DF-352B055F6093Q34627778-5BD6B561-39F4-4EE5-B682-38E57320CB41Q35098737-2293F84D-132F-4758-9CBC-CF0669C43567Q35868633-FE32279F-C82F-416F-9C89-CDD461EE7312Q36819891-25801EB8-D54A-40F3-B8EE-0CE77F9E7E3EQ36924398-26DA6F73-2943-478B-A645-CA517AF1DFF6Q36945907-46B77E60-AEFF-4BAD-B283-9012CA3CFF75Q37047173-6DE05553-E662-43F9-ABAB-AC332BFC741AQ37578873-4F895FC4-C3FE-42D0-AC39-6EE7AC91E772Q37638250-60A3C226-AEB8-4AED-8829-5FDB316FC5BDQ38035575-66697A8F-44CD-4EB1-B7CA-E998C0C6AB2CQ38563903-DEA53FB7-A715-449E-9372-58A17B665224Q39539160-02F3E906-7695-4428-8C47-1F9B016112BEQ40159308-4F0CCA5D-609A-478B-B98C-933E69148E10Q41276097-8709FC30-A574-461E-AF77-8447E6652A4CQ47652218-6A84F58B-D05F-4718-9AD8-BD19D2A8CE07Q52630787-F263BD01-A98E-41EB-8DFB-F3E6B39CE65AQ52723992-B93A7DC7-569A-4478-BD8F-4EA2C92619BFQ57132246-C90CF29B-8392-4970-B95E-FE8C2A5AD21C
P2860
Desquamation of human coronary artery endothelium by human mast cell proteases: implications for plaque erosion.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Desquamation of human coronary ...... plications for plaque erosion.
@en
Desquamation of human coronary ...... plications for plaque erosion.
@nl
type
label
Desquamation of human coronary ...... plications for plaque erosion.
@en
Desquamation of human coronary ...... plications for plaque erosion.
@nl
prefLabel
Desquamation of human coronary ...... plications for plaque erosion.
@en
Desquamation of human coronary ...... plications for plaque erosion.
@nl
P2093
P1476
Desquamation of human coronary ...... plications for plaque erosion.
@en
P2093
Hanna M Heikkilä
Ken A Lindstedt
Petri T Kovanen
P304
P356
10.1097/01.MCA.0000224420.67304.4D
P577
2006-11-01T00:00:00Z